China Money Network
Login
Join

Chinese Biotech Firm Ascletis First To File For Hong Kong IPO Under New Listing Rules

  • May 8, 2018 — 10:38 CST

This Data Is Locked!

This area is available only to Subscribers.

Ascletis Pharma, a Hangzhou-based biotechnology firm, has filed to list on the Hong Kong Stock Exchange, making it the first company to exploit the new... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: